Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.21064389473762.4515
Domestic EquitiesCipla Ltd.9.40214742991639.4500
Domestic EquitiesMankind Pharma Ltd.7.64332312842519.8344
Domestic EquitiesDr. Reddy's Laboratories Ltd.6.52283448866443.6276
Domestic EquitiesBiocon Ltd.6.203510823731421.9090
Domestic EquitiesDivi's Laboratories Ltd.5.9452630948404.3430
Domestic EquitiesLupin Ltd.3.98521177453271.0379
Domestic EquitiesAurobindo Pharma Ltd.3.69632059889251.3889
Domestic EquitiesAlkem Laboratories Ltd.3.4682418259235.8772
Domestic EquitiesSyngene International Ltd.3.16385096498215.1741
Domestic EquitiesCohance Lifesciences Ltd.2.77156081373188.4922
Domestic EquitiesMedplus Health Services Ltd2.53582034769172.4670
Domestic EquitiesAlivus Life Sciences Ltd.2.11381576714143.7648
Domestic EquitiesZydus Lifesciences Ltd.2.07181528792140.9088
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.1.77072467084120.4307
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.7474578725118.8412
Domestic EquitiesThyrocare Technologies Ltd.1.74543015486118.7046
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.60091530979108.8832
Domestic EquitiesGland Pharma Ltd.1.5403574908104.7597
Domestic EquitiesEntero Healthcare Solutions1.458996145599.2222
Domestic EquitiesPfizer Ltd.1.343018043091.3373
Domestic EquitiesMedi Assist Healthcare Services Ltd1.3123240773989.2549
Domestic EquitiesBlue Jet Healthcare Ltd.1.2176204315882.8092
Domestic EquitiesMetropolis Healthcare Ltd.1.209943223382.2885
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.190137882280.9429
Domestic EquitiesFine Organic Industries Ltd.1.168116866679.4467
Domestic EquitiesHikal Ltd.1.1536398912878.4582
Domestic EquitiesAnthem Biosciences Ltd1.0853105263673.8161
Domestic EquitiesAarti Drugs Ltd.0.9843182416766.9469
Domestic EquitiesShilpa Medicare Ltd.0.9699195953165.9676
Domestic EquitiesWindlas Biotech Ltd.0.952185765164.7527
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.881413352559.9434
Domestic EquitiesAstrazeneca Pharma India Ltd.0.75835828251.5737
Domestic EquitiesSenores Pharmaceuticals Ltd0.711563267048.3929
Domestic EquitiesFDC Ltd.0.6281119768942.7156
Domestic EquitiesLaxmi Dental Ltd.0.6251220785942.5167
Domestic EquitiesNephrocare Health Services Ltd0.480154991732.6541
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.4509241330830.6683
Domestic EquitiesRubicon Research Ltd0.260622710117.7218
Total 97.9800 6663.7755
Cash & Cash Equivalents and Net AssetsTREPS2.1790 148.2007
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.0060 0.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1942 -13.2084
Total 1.9908 135.3975
Treasury Bills91 Days Treasury Bills0.02922000001.9891
Total 0.0292 1.9891
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.